Skip to main navigation Skip to search Skip to main content

An Open Phase II Multi-center Trial of BAY59-8862 Patients with Aggressive Refractory Non-Hodgkins Lymphoma

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date09/1/01 → 09/30/03

Funding

  • Bayer Corporation: $9,281.23